scholarly journals Delivering High-Quality and Affordable Care Throughout the Cancer Care Continuum

2013 ◽  
Vol 31 (32) ◽  
pp. 4151-4157 ◽  
Author(s):  
Ya-Chen Tina Shih ◽  
Patricia A. Ganz ◽  
Denise Aberle ◽  
Amy Abernethy ◽  
Justin Bekelman ◽  
...  
Keyword(s):  
Cancer Care ◽  
Primary Care Physicians ◽  
New Technologies ◽  
Financial Burden ◽  
The United States ◽  
Institute Of Medicine ◽  
High Quality ◽  
Care Continuum ◽  
Quality Cancer Care ◽  
Cancer Care Continuum

The national cost of cancer care is projected to reach $173 billion by 2020, increasing from $125 billion in 2010. This steep upward cost trajectory has placed enormous an financial burden on patients, their families, and society as a whole and raised major concern about the ability of the health care system to provide and sustain high-quality cancer care. To better understand the cost drivers of cancer care and explore approaches that will mitigate the problem, the National Cancer Policy Forum of the Institute of Medicine held a workshop entitled “Delivering Affordable Cancer Care in the 21st Century” in October 2012. Workshop participants included bioethicists, health economists, primary care physicians, and medical, surgical, and radiation oncologists, from both academic and community settings. All speakers expressed a sense of urgency about the affordability of cancer care resulting from the future demographic trend as well as the high cost of emerging cancer therapies and rapid diffusion of new technologies in the absence to evidence indicating improved outcomes for patients. This article is our summary of presentations at the workshop that highlighted the overuse and underuse of screening, treatments, and technologies throughout the cancer care continuum in oncology practice in the United States.

Practice-Changing Strategies to Deliver Affordable, High-Quality Cancer Care: Summary of an Institute of Medicine Workshop

2013 ◽  
Vol 9 (6S) ◽  
pp. 54s-59s ◽  
Author(s):  
Erin P. Balogh ◽  
Peter B. Bach ◽  
Peter D. Eisenberg ◽  
Patricia A. Ganz ◽  
Robert J. Green ◽  
...  
Keyword(s):  
Quality Of Care ◽  
21St Century ◽  
Cancer Care ◽  
Institute Of Medicine ◽  
High Quality ◽  
Quality Cancer Care

The authors summarize presentations and discussion from the Delivering Affordable Cancer Care in the 21st Century workshop and focus on proposed strategies to improve the affordability of cancer care while maintaining or improving the quality of care.

Successful Strategies to Address Disparities: Insurer and Employer Perspectives

2020 ◽  
pp. 292-300
Author(s):  
Manali I. Patel ◽  
Richard Snyder ◽  
Otis Brawley
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Low Income ◽  
Cancer Care ◽  
Care Delivery ◽  
The United States ◽  
Cancer Disparities ◽  
Care Providers ◽  
High Quality ◽  
Quality Cancer Care

Disparities in cancer have been documented for decades and continue to persist despite clinical advancements in cancer prevention, detection, and treatment. Disparate cancer outcomes continue to affect many populations in the United States and globally, including racial and ethnic minorities, populations with low income and education, and residents of rural areas or low socioeconomic neighborhoods, among others. Addressing cancer disparities requires approaches that are multilevel. Addressing social determinants of health, such as removing obstacles to health (e.g., poverty, discrimination, access to housing and education, jobs with fair pay, and health care) can reduce cancer disparities. However, to achieve cancer health equity, multilevel approaches are required to ensure that access to high-quality cancer care and equitable receipt of evidence-based services can reduce cancer disparities. Policy, health system interventions, and innovative delivery and health care coverage approaches by private and public payers, employer-based payers, and labor union organizations can assist in ensuring access to and receipt of high-quality cancer care while addressing the high costs of care delivery. Partnerships among patients, caregivers, employers, health care providers, and health care payers can make impactful changes in the way in which cancer care is delivered and, in turn, can assist in reducing cancer disparities.

Challenges and Opportunities in Delivering High-Quality Cancer Care: A 2016 Update

2016 ◽  
pp. e294-e300
Author(s):  
Patricia A. Ganz ◽  
Michael J. Hassett ◽  
David C. Miller
Keyword(s):  
Cancer Care ◽  
Care Delivery ◽  
Quality Measurement ◽  
Quality Measures ◽  
The United States ◽  
Institute Of Medicine ◽  
Patients With Cancer ◽  
Quality Cancer Care ◽  
Challenges And Opportunities ◽  
Quality Improvement Collaboratives

Herein, both the rationale and scope of current initiatives aimed at improving the quality of cancer care delivery in the United States are described. First, we discuss a recent report from the Institute of Medicine that issued a strong call for both the development of quality measures in oncology and implementation of a learning health care system in which data and experience from clinical practice can inform continuous improvements in cancer care. Second, we review the multiple, diverse initiatives that are underway to identify, test, and validate quality measures for the entire spectrum of cancer care. Finally, we discuss regional quality improvement collaboratives as one successful approach to creating a cycle of quality measurement, identification of best practices, and implementation of changes in practice patterns that ultimately yield improved care and outcomes for patients with cancer.

scholarly journals Gap between desired and self-determined roles of general practitioners: a multicentre questionnaire study in Japan

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Takashi Chinen ◽  
Yusuke Sasabuchi ◽  
Kazuhiko Kotani ◽  
Hironori Yamaguchi
Keyword(s):  
Palliative Care ◽  
General Practitioners ◽  
Cancer Care ◽  
Primary Care Physicians ◽  
Survivorship Care ◽  
Web Based ◽  
Care Continuum ◽  
Cancer Care Continuum ◽  
Cancer Specialists

Abstract Background Primary care physicians have diverse responsibilities. To collaborate with cancer specialists efficiently, they should prioritise roles desired by other collaborators rather than roles based on their own beliefs. No previous studies have reported the priority of roles such clinic-based general practitioners are expected to fulfil across the cancer care continuum. This study clarified the desired roles of clinic-based general practitioners to maximise person-centred cancer care. Methods A web-based multicentre questionnaire in Japan was distributed to physicians in 2019. Physician roles within the cancer care continuum were divided into 12 categories, including prevention, diagnosis, surgery, follow-up with cancer survivors, chemotherapy, and palliative care. Responses were evaluated by the proportion of three high-priority items to determine the expected roles of clinic-based general practitioners according to responding physicians in similarly designated roles. Results Seventy-eight departments (25% of those recruited) from 49 institutions returned questionnaires. Results revealed that some physicians had lower expectations for clinic-based general practitioners to diagnose cancer, and instead expected them to provide palliative care. However, some physicians expected clinic-based general practitioners to be involved in some treatment and survivorship care, though the clinic-based general practitioners did not report the same priority. Conclusion Clinic-based general practitioners prioritised involvement in prevention, diagnoses, and palliative care across the cancer continuum, although lower expectations were placed on them than they thought. Some additional expectations of their involvement in cancer treatment and survivorship care were unanticipated by them. These gaps represent issues that should be addressed.

Results of a multistate, multi-institution implementation of a multidisciplinary cancer conference quality measurement tool.

2021 ◽  
Vol 39 (28_suppl) ◽  
pp. 212-212
Author(s):  
Lijo Simpson ◽  
Anju Mathew ◽  
Robert Wojciechowski ◽  
Irina Hill
Keyword(s):  
Clinical Trials ◽  
Cancer Care ◽  
Quality Measurement ◽  
The United States ◽  
Quality Metrics ◽  
Lower Percentage ◽  
High Quality ◽  
Quality Cancer Care ◽  
Psychosocial Counselling ◽  
Virtual Platform

212 Background: The 2006 ASCO and the ESMO consensus statement on quality cancer care defined the delivery of multimodality treatment by a multidisciplinary team of appropriately skilled health professionals as an essential component of quality cancer care. Furthermore, MDCs have demonstrated improved survival in breast, head and neck, ovarian and colorectal cancers. Despite these advantages, health care systems struggle to implement and sustain MDCs due to the heavy burden imposed by the required work processes. We report on the large-scale utilization of a propriety quality measurement platform OncoLens to run MDCs across the country. Methods: Technology quality metrics were collected from the ongoing daily usage of the platform including cancer characteristics, care team utilization metrics, average attendance, quality metrics collected for accreditation and clinical trials matching on the OncoLens platform. Results: The virtual platform was accessible to around 8000 providers across the United States. In 2020, 13771 cases were discussed. Attendance of the required specialties for high quality care of Medical Oncology, Radiation Oncology, Surgery, Pathology and Radiology was attained, with the average conference attendance being 14. Race/ethnicity data on the cases revealed White (9197, 67%), Black (1817,13%), Hispanic (363,3%) and Other (2356,17%). Optional quality metrics were collected during discussions for CoC, NAPBC and NAPRC accreditation. These included NCCN guidelines discussed, Staging discussed, clinical trials discussed, Genetics discussion, palliative care discussion, rehabilitation services, reproductive counselling discussed, psychosocial counselling discussed, nutritional counselling discussed, reconstructive surgery discussion, tobacco cessation discussion across General and Site-specific conferences. Most of the case presentations were prospective. This format does enable cancer programs to collect quality metrics around Cancer program accreditation by the American College of Surgeons. 66% of patients discussed potentially matched to clinical trials during the discussion. Conclusions: A technology platform can assist cancer programs to collect quality metrics around cancer care. This gives them the ability to run data driven quality programs targeting specific quality metrics. Hispanics have a lower percentage of cases presented at MDC compared to other race/ethnicities. It is possible to have high quality discussions and attain metrics for Commission on Cancer accreditation utilizing a virtual platform.

Institute of Medicine Report on Delivery of High-Quality Cancer Care

2014 ◽  
Vol 10 (3) ◽  
pp. 193-195 ◽  
Author(s):  
Patricia A. Ganz
Keyword(s):  
Cancer Care ◽  
Institute Of Medicine ◽  
High Quality ◽  
Quality Cancer Care ◽  
Care System

The Institute of Medicine saw a cancer care system in crisis. This article highlights the key findings of its report and recommendations.

Cost-Related Health Literacy: A Key Component of High-Quality Cancer Care

2015 ◽  
Vol 11 (3) ◽  
pp. 171-173 ◽  
Author(s):  
S. Yousuf Zafar ◽  
Peter A. Ubel ◽  
James A. Tulsky ◽  
Kathryn I. Pollak
Keyword(s):  
Health Literacy ◽  
Cancer Treatment ◽  
Cancer Care ◽  
Institute Of Medicine ◽  
Financial Toxicity ◽  
High Quality ◽  
Quality Cancer Care ◽  
Short And Long Term

Because cancer treatment can result in both short- and long-term financial harm known as financial toxicity; the Institute of Medicine has issued a challenge to improve patients' understanding of cost of cancer care.

Sign in / Sign up

Export Citation Format

Share Document